Can shared music listening ease the strain of dementia care?

NCT ID NCT07843043

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 25, 2026 · Last updated Sep 25, 2026

Summary

Researchers at Duke University are testing a six-week music-based program for people with dementia and their family caregivers. Each week, an interventionist meets with the pair for 45 minutes to guide shared music listening and teach skills for choosing meaningful songs and talking about them together. The study measures whether pairs complete the program, find it acceptable, and show early signs of benefit. Sixty pairs will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a structured shared music listening program for people with dementia and their care partners
What this could lead to
If it works, this could offer a low-cost, home-based activity that helps people with dementia and their care partners connect and cope. It could also shape larger trials testing music for mood, memory, and relationship quality.
What could go wrong
This is a small feasibility study, so it cannot prove the program improves symptoms or slows dementia. Dyads may drop out, and any benefits seen might come from attention and social contact rather than music itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2027

An estimate. Start dates often move.

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion for patient: 1. Age 60 and older 2. Existing physician diagnosis of dementia or self-reported memory impairment and Telephone Montreal Cognitive Assessment (T-MoCA) score between 18-25 with a capacity to consent. We chose the T-MoCA because it is ideal for subjects with visual impairment in a remote setting. Shown to be detection at remote detection of cognitive impairment. 3. Care partner or PLWD reporting current or past (8-12 months) dissatisfaction with the relationship score (score of 3 or less on the relationship satisfaction measure) given a dissatisfaction for one member of the dyad will affect the other person. 4. Stable dose of psychotropic medications, sedatives/hypnotics, anti-dementia or opioids in the past 60 days prior to enrollment to minimize the confounding effects of medications. Exclusion for patient: 1. Hearing impairment (defined as inability to hear a normal speaking voice at distance of 1-1/2 feet) to exclude those who cannot hear the music intervention. 2. Planned transition to a residental or institutional care setting in less than 3 months (to decrease attrition). 3. Currently enrolled in an interventional clinical trial for PLWD aimed to improve relationship quality (to not confound the results) 4. Receiving hospice services. Inclusion for care partner: 1. Must reside with the patient. 2. At least 21 years of age. 3. Self-identify as the primary care partner 4. Able to speak and read English 5. If on psychotropic medications at the time of telephone screen must be on a stable dose of the medication for 60 days prior to enrollment. 6. Consider themselves a family member (blood or non-blood relative) Exclusion for care partner: 1. Do not reside with patient 2. Under the age of 21 years of age 3. Is not primary care partner 4. Not able to speak and read English 5. Has not been on a stable dose of psychotropic medications prior 60 to enrollment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Duke University

    Durham, North Carolina, 27710, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.